Aprill Kee Oliva Mizushima, Meryem Bouhoute, Meriem Bejaoui, Farhana Ferdousi, Mitsutoshi Nakajima and Hiroko Isoda*,
{"title":"Pentacyclic Triterpenoid Maslinic Acid Promotes Hair Growth Comparable to Minoxidil: A New Insight on the Potential Involvement of Cilia Activity","authors":"Aprill Kee Oliva Mizushima, Meryem Bouhoute, Meriem Bejaoui, Farhana Ferdousi, Mitsutoshi Nakajima and Hiroko Isoda*, ","doi":"10.1021/acsptsci.5c00189","DOIUrl":null,"url":null,"abstract":"<p >Maslinic acid is a pentacyclic triterpene component of olive extracts. In this study, we elucidated the effects of maslinic acid on hair growth and explored its underlying mechanisms. The topical application of maslinic acid stimulates hair growth in mice comparable to minoxidil, where an acceleration in anagen induction was observed. Moreover, treatment with maslinic acid led to increased protein levels of CTNNB1 and VEGF, and upregulated the mRNA expression of trichogenic genes, including <i>CTNNB1, ALPL,</i> and <i>FGF1</i>. Additionally, crucial pathways and biological processes involved in hair growth were activated such the Wnt, Notch, MAPK, and angiogenesis. Interestingly, <i>Iqcb1</i>, a ciliogenesis-promoting gene, was found to be upregulated by maslinic acid, leading us to explore the potential link between hair growth and cilia activity. Notably, inhibiting cilia activity resulted in the downregulation of <i>CTNNB1.</i> Altogether, our study suggests that maslinic acid stimulates hair growth through the Wnt/β-catenin pathway and introduces a possible mechanism involving ciliary gene activity.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 8","pages":"2586–2599"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsptsci.5c00189","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.5c00189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Maslinic acid is a pentacyclic triterpene component of olive extracts. In this study, we elucidated the effects of maslinic acid on hair growth and explored its underlying mechanisms. The topical application of maslinic acid stimulates hair growth in mice comparable to minoxidil, where an acceleration in anagen induction was observed. Moreover, treatment with maslinic acid led to increased protein levels of CTNNB1 and VEGF, and upregulated the mRNA expression of trichogenic genes, including CTNNB1, ALPL, and FGF1. Additionally, crucial pathways and biological processes involved in hair growth were activated such the Wnt, Notch, MAPK, and angiogenesis. Interestingly, Iqcb1, a ciliogenesis-promoting gene, was found to be upregulated by maslinic acid, leading us to explore the potential link between hair growth and cilia activity. Notably, inhibiting cilia activity resulted in the downregulation of CTNNB1. Altogether, our study suggests that maslinic acid stimulates hair growth through the Wnt/β-catenin pathway and introduces a possible mechanism involving ciliary gene activity.
期刊介绍:
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.